Jenscare Scientific Co (HKSE:09877) Short-Term Debt & Capital Lease Obligation : HK$19.23 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Jenscare Scientific Co Short-Term Debt & Capital Lease Obligation?

Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. Jenscare Scientific Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$19.23 Mil.

Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. Jenscare Scientific Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was HK$49.55 Mil.

Jenscare Scientific Co Short-Term Debt & Capital Lease Obligation Historical Data

The historical data trend for Jenscare Scientific Co's Short-Term Debt & Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jenscare Scientific Co Short-Term Debt & Capital Lease Obligation Chart

Jenscare Scientific Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt & Capital Lease Obligation

2.16

1.64

2.57

2.10

19.23

Jenscare Scientific Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Short-Term Debt & Capital Lease Obligation	Get a 7-Day Free Trial				2.57	2.44	2.10	2.86	19.23

Jenscare Scientific Co Short-Term Debt & Capital Lease Obligation Calculation

This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.

In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Jenscare Scientific Co Short-Term Debt & Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Jenscare Scientific Co's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Jenscare Scientific Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jenscare Scientific Co Ltd (HKSE:09877) » Definitions » Short-Term Debt & Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 777 Binhai 4th Road, Block 5, B Area, Hangzhou Bay New Area, Zhejiang Province, Ningbo, CHN

Website

https://www.jenscare.com

Jenscare Scientific Co Ltd is engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.

Executives

Lv Shiwen	2501 Other
Li Hui	2501 Other
Shanghai Shidi Industrial Development Co., Ltd.	2501 Other
Ningbo Linfeng Biotechnology Co., Ltd.	2101 Beneficial owner
Onez International Limited	2101 Beneficial owner
Pan Fei	2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited	2301 Trustee
Trinity Elite I International Limited	2201 Interest of corporation controlled by you
Ningbo Dixiang Venture Capital Co., Ltd.	2201 Interest of corporation controlled by you
Shanghai Jiachen Investment Co.,ltd	2201 Interest of corporation controlled by you
Ningbo Sangdi Investment Management L.p. (limited Partnership)	2101 Beneficial owner
Hainan Yize Medical Technology Co., Limited	2201 Interest of corporation controlled by you
Hainan Maidi Enterprise Management L.p. (limited Partnership)	2101 Beneficial owner
Hainan Hualing Investment L.p. (limited Partnership)	2101 Beneficial owner
Hangzhou Chende Investment Partnership (limited Partnership)	2101 Beneficial owner

Jenscare Scientific Co Headlines

No Headlines